Cardiorenal syndrome: Ultrafiltration therapy for heart failure- Trials and tribulations

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 10, 2013, Pages 1816-1828

  Kazory, Amir ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CYSTATIN C; DIURETIC AGENT; NEUROHORMONE; TOLVAPTAN; VASOPRESSIN RECEPTOR ANTAGONIST;

ACUTE HEART FAILURE; ALDOSTERONE BLOOD LEVEL; ANTICOAGULATION; ARTICLE; CARDIORENAL SYNDROME; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL (TOPIC); CONTINUOUS HEMODIAFILTRATION; CONTROLLED CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; DRUG HYPERSENSITIVITY; ELECTROLYTE DISTURBANCE; GLOMERULUS FILTRATION; HEART FAILURE; HOSPITAL READMISSION; HUMAN; HYPERSENSITIVITY; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LENGTH OF STAY; NATRIURESIS; OTOTOXICITY; PLASMA RENIN ACTIVITY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BLOOD LEVEL; SODIUM RETENTION; SYSTEMIC VASCULAR RESISTANCE; ULTRAFILTRATION; URINE VOLUME; VENOUS CONGESTION; WEIGHT REDUCTION;

HEART FAILURE; HUMANS; KIDNEY; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 84885216892     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02910313     Document Type: Article

References (59)

1. Wier LM, Pfuntner A, Maeda J, Stranges E, Ryan K, Jagadish P, Collins Sharp B, Elixhauser A: HCUP Facts and Figures: Statistics on Hospital-based Care in the United States, 2009. Rockville, MD: Agency for Healthcare Research and Quality, 2011. Available at: http://www.hcup-us.ahrq.gov/reports.jsp. Accessed March 6, 2013
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 123: e18-e209, 2011
3. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ; American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research: Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation 123: 933-944, 2011
4. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP; ADHERE Scientific Advisory Committee and Investigators: Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149: 209-216, 2005
5. Jencks SF, Williams MV, Coleman EA: Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360: 1418-1428, 2009
6. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146, 2008
7. Fang J, Mensah GA, Croft JB, Keenan NL: Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 52: 428-434, 2008
8. 111th US Congress: The Patient Protection and Affordable Care Act, 2010. Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/html/PLAW-111publ148.htm. Accessed March 6, 2013
9. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW: Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140: 840-847, 2000
10. Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G: Dyspnoea in patients with acute heart failure: An analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail 12: 499-507, 2010
11. Metra M, Teerlink JR, Felker GM, Greenberg BH, Filippatos G, Ponikowski P, Teichman SL, Unemori E, Voors AA, Weatherley BD, Cotter G: Dyspnoea and worsening heart failure in patients with acute heart failure: Results from the Pre-RELAX-AHF study. Eur J Heart Fail 12: 1130-1139, 2010
12. Gheorghiade M, Filippatos G: Reassessing treatment of acute heart failure syndromes: The ADHERE Registry. Eur Heart J 7[suppl B]: B13-B19, 2005
13. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW; ESCAPE Investigators and ESCAPE Study Coordinators: Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 294: 1625-1633, 2005
14. Hata N, Yokoyama S, Shinada T, Kobayashi N, Shirakabe A, Tomita K, Kitamura M, Kurihara O, Takahashi Y: Acute kidney injury and outcomes in acute decompensated heart failure: Evaluation of the RIFLE criteria in an acutely ill heart failure population. Eur J Heart Fail 12: 32-37, 2010
15. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43: 61-67, 2004
16. Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KF Jr: Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE trial. Eur J Heart Fail 9: 1064-1069, 2007
17. Mielniczuk LM, Tsang SW, Desai AS, Nohria A, Lewis EF, Fang JC, Baughman KL, Stevenson LW, Givertz MM: The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients. J Card Fail 14: 388-393, 2008
18. Kazory A, Ross EA: Emerging therapies for heart failure: Renal mechanisms and effects. Heart Fail Rev 17: 1-16, 2012
19. Guazzi MD, Agostoni P, Perego B, Lauri G, Salvioni A, Giraldi F, Matturri M, Guazzi M, Marenzi G: Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 72: 534-539, 1994
20. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P: Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38: 963-968, 2001
21. Agostoni P, Marenzi G, Lauri G, Perego G, Schianni M, Sganzerla P, Guazzi MD: Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result. Am J Med 96: 191-199, 1994
22. Giglioli C, Landi D, Cecchi E, Chiostri M, Gensini GF, Valente S, Ciaccheri M, Castelli G, Romano SM: Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: The ULTRADISCO study. Eur J Heart Fail 13: 337-346, 2011
23. Giglioli C, Landi D, Gensini GF, Valente S, Cecchi E, Scolletta S, Chiostri M, Romano SM: Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: A preliminary report. Blood Purif 29: 44-51, 2010
24. Bart BA: Treatment of congestion in congestive heart failure: Ultrafiltration is the only rational initial treatment of volume overload in decompensated heart failure. Circ Heart Fail 2: 499-504, 2009
25. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA 297: 1319-1331, 2007
26. Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, Mackedanz S, Sobotka PA, Schollmeyer M, Goldsmith SR: Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 46: 2043-2046, 2005
27. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA; UNLOAD Trial Investigators: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49: 675-683, 2007
28. Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA; Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure (UNLOAD) Investigators: Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: Results from UNLOAD. J Card Fail 16: 277-284, 2010
29. Agostoni PG, Marenzi GC, Pepi M, Doria E, Salvioni A, Perego G, Lauri G, Giraldi F, Grazi S, Guazzi MD: Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 21: 424-431, 1993
30. Pepi M, Marenzi GC, Agostoni PG, Doria E, Barbier P, Muratori M, Celeste F, Guazzi MD: Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: Pathophysiological correlates. Br Heart J 70: 135-140, 1993
31. Winton FR: The influence of venous pressure on the isolated mammalian kidney. J Physiol 72: 49-61, 1931
32. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53: 582-588, 2009
33. Guglin M, Rivero A, Matar F, Garcia M: Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol 34: 113-116, 2011
34. Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH: Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 14: 508-514, 2008
35. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW: Treatment of severe fluid overload by ultrafiltration. N Engl J Med 291: 747-751, 1974
36. Sharma A, Hermann DD, Mehta RL: Clinical benefit and approach of ultrafiltration in acute heart failure. Cardiology 96: 144-154, 2001
37. Canaud B, Leblanc M, Leray-Moragues H, Delmas S, Klouche K, Beraud JJ: Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 13[SUPPL 4]: 51-55, 1998
38. Jaski BE, Ha J, Denys BG, Lamba S, Trupp RJ, Abraham WT: Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 9: 227-231, 2003
39. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P: Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 46: 2047-2051, 2005
40. Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E; Heart Failure Clinical Research Network: Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367: 2296-2304, 2012
41. Dev S, Shirolkar SC, Stevens SR, Shaw LK, Adams PA, Felker GM, Rogers JG, O'Connor CM: Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure. Cardiology 123: 145-153, 2012
42. Patarroyo M, Wehbe E, Hanna M, Taylor DO, Starling RC, Demirjian S, Tang WH: Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol 60: 1906-1912, 2012
43. Barsuk JH, Gordon RA, Cohen ER, Cotts WG, Malkenson D, Yancy CW, Williams MV: A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure. Congest Heart Fail 19: 53-60, 2013
44. Kazory A, Ross EA: Ultrafiltration for decompensated heart failure: Renal implications. Heart 95: 1047-1051, 2009
45. Liang KV, Hiniker AR, Williams AW, Karon BL, Greene EL, Redfield MM: Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: Initial clinical experience in a single center. J Card Fail 12: 707-714, 2006
46. Bartone C, Saghir S, Menon SG, Brosmer J, Kereiakes DJ, Mazur W, Chung ES: Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure. Congest Heart Fail 14: 298-301, 2008
47. Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, Gottlieb SS: A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail 14: 1-5, 2008
48. Bradley SM, Levy WC, Veenstra DL: Cost-consequences of ultrafiltration for acute heart failure: A decision model analysis. Circ Cardiovasc Qual Outcomes 2: 566-573, 2009
49. Kazory A, Ejaz AA, Ross EA: Ultrafiltration for heart failure: How fast should we move? Am Heart J 157: 205-207, 2009
50. Kazory A, Bellamy FB, Ross EA: Ultrafiltration for acute decompensated heart failure: Financial implications. Int J Cardiol 154: 246-249, 2012
51. Kazory A, Ross EA: Contemporary trends in the pharmacological and extracorporeal management of heart failure: A nephrologic perspective. Circulation 117: 975-983, 2008
52. Kazory A: Ultrafiltration does not affect certain predictors of outcome in heart failure. Int J Cardiol 143: 1-3, 2010
53. Hanna MA, Tang WH, Teo BW, O'Neill JO, Weinstein DM, Lau SM, Van Lente F, Starling RC, Paganini EP, Taylor DO: Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congest Heart Fail 18: 54-63, 2012
54. Kazory A: Need for a unified decision-making tool for ultrafiltration therapy in heart failure; call for action. Am Heart J 159: 505-507, 2010
55. Dahle TG, Blake D, Ali SS, Olinger CC, Bunte MC, Boyle AJ: Large volume ultrafiltration for acute decompensated heart failure using standard peripheral intravenous catheters. J Card Fail 12: 349-352, 2006
56. Jaski BE, Romeo A, Ortiz B, Hoagland PM, Stone M, Glaser D, Thomas L, Walsh C, Smith SC Jr: Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration. J Card Fail 14: 515-520, 2008
57. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479, 2009
58. McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A, Estrella-Holder E, Giannetti N, Grzeslo A, Harkness K, Howlett JG, Kouz S, Leblanc K, Mann E, Nigam A, O'Meara E, Rajda M, Steinhart B, Swiggum E, Le VV, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Rao V, Ross HJ, Sussex B: The 2012 Canadian Cardiovascular Society heart failure management guidelines update: Focus on acute and chronic heart failure. Can J Cardiol 29: 168-181, 2013
59. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33: 1787-1847, 2012